Detalhe da pesquisa
1.
Divergent clinical outcomes in a phase 2B trial of the TLPLDC vaccine in preventing melanoma recurrence and the impact of dendritic cell collection methodology: a randomized clinical trial.
Cancer Immunol Immunother
; 72(3): 697-705, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36045304
2.
Immunologic and dose dependent effects of rapamycin and its evolving role in chemoprevention.
Clin Immunol
; 245: 109095, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35973640
3.
Subgroup analysis of nelipepimut-S plus GM-CSF combined with trastuzumab versus trastuzumab alone to prevent recurrences in patients with high-risk, HER2 low-expressing breast cancer.
Clin Immunol
; 225: 108679, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33485895
4.
Correlation of tumor microenvironment from biopsy and resection specimens in untreated colorectal cancer patients: a surprising lack of agreement.
Cancer Immunol Immunother
; 70(5): 1465-1474, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33180182
5.
A Phase IIb Randomized Controlled Trial of the TLPLDC Vaccine as Adjuvant Therapy After Surgical Resection of Stage III/IV Melanoma: A Primary Analysis.
Ann Surg Oncol
; 28(11): 6126-6137, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-33641012
6.
Acidic conditions in the NHE2(-/-) mouse intestine result in an altered mucosa-associated bacterial population with changes in mucus oligosaccharides.
Cell Physiol Biochem
; 32(7): 111-28, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24429819
7.
Prospective, randomized, double-blind phase 2B trial of the TLPO and TLPLDC vaccines to prevent recurrence of resected stage III/IV melanoma: a prespecified 36-month analysis.
J Immunother Cancer
; 11(8)2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37536936
8.
Chemoprevention in familial adenomatous polyposis: past, present and future.
Fam Cancer
; 20(1): 23-33, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32507936
9.
Phase I Trial of Encapsulated Rapamycin in Patients with Prostate Cancer Under Active Surveillance to Prevent Progression.
Cancer Prev Res (Phila)
; 14(5): 551-562, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33514567
10.
Safety and efficacy of autologous tumor lysate particle-loaded dendritic cell vaccination in combination with systemic therapies in patients with recurrent and metastatic melanoma.
Melanoma Res
; 31(4): 378-388, 2021 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34193804
11.
Multi-institutional, prospective, randomized, double-blind, placebo-controlled phase IIb trial of the tumor lysate, particle-loaded, dendritic cell (TLPLDC) vaccine to prevent recurrence in high-risk melanoma patients: A subgroup analysis.
Cancer Med
; 10(13): 4302-4311, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33982452
12.
Results of a Randomized Phase IIb Trial of Nelipepimut-S + Trastuzumab versus Trastuzumab to Prevent Recurrences in Patients with High-Risk HER2 Low-Expressing Breast Cancer.
Clin Cancer Res
; 26(11): 2515-2523, 2020 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32071118